Faculty

Timothy Wilens

MD
Chief, Division of Child and Adolescent Psychiatry
McLean and Massachusetts General Hospitals;
Professor of Psychiatry, Harvard Medical School

Timothy Edwin Wilens, MD is Professor of Psychiatry at Harvard Medical School. Additionally, he is Chief of Child and Adolescent Psychiatry at Massachusetts General (MGH)/McLean/Brigham and Women’s Hospitals; and is senior staff and director of substance use services in the Pediatric Psychopharmacology Clinic and Research Program at the MGH in Boston, MA.

Dr. Wilens earned his medical degree from the University of Michigan Medical School in Ann Arbor. He went on to complete his residency in psychiatry at Massachusetts General Hospital. He is certified by the American Board of Psychiatry and Neurology in General Psychiatry, Child and Adolescent Psychiatry, and Addiction Psychiatry.

Specializing in the diagnosis and pharmacological treatment of children and adults with ADHD, bipolar, substance use disorders, and other psychopathological conditions, Dr. Wilens cares for patients, supervises clinical trials, and consults on difficult cases.

Widely published, Dr. Wilens has more than 550 original articles, reviews, chapters, and editorials to his credit; and has written or coedited 6 books. He is a regular presenter at national and international meetings and sought as a speaker outside his academic responsibilities. He serves on the editorial boards of several journals and is a reviewer for many other journals. He is a distinguished fellow in the American Psychiatric Association and the American Academy of Child and Adolescent Psychiatry - where he also serves as President-elect.

2026 Sessions

ADHD With Comorbidities: Anxiety, Mood Disorders, Autism, and Substance Use Disorders

Comorbidity is the rule, not the exception, in ADHD, often complicating diagnosis and treatment planning. This session examines clinical challenges when ADHD co-occurs with anxiety disorders, mood disorders, autism spectrum disorder, and substance use disorders. Faculty will address strategies for diagnostic clarification, sequencing treatments, and balancing symptom control with risks such as stimulant misuse or mood destabilization. Discussion will emphasize pharmacotherapeutic interventions while also discussing integrative approaches that combine medication management with psychotherapy, environmental supports, and functional interventions. Attendees will gain practical frameworks for treating ADHD within complex, real-world presentations marked by overlapping diagnoses and significant functional impairment.

Speaker

Wednesday, September 16 9:00–10:00 AM
Room Great Hall B
Faculty

Timothy Wilens

MD
Chief, Division of Child and Adolescent Psychiatry
McLean and Massachusetts General Hospitals;
Professor of Psychiatry, Harvard Medical School

Timothy Edwin Wilens, MD is Professor of Psychiatry at Harvard Medical School. Additionally, he is Chief of Child and Adolescent Psychiatry at Massachusetts General (MGH)/McLean/Brigham and Women’s Hospitals; and is senior staff and director of substance use services in the Pediatric Psychopharmacology Clinic and Research Program at the MGH in Boston, MA.

Dr. Wilens earned his medical degree from the University of Michigan Medical School in Ann Arbor. He went on to complete his residency in psychiatry at Massachusetts General Hospital. He is certified by the American Board of Psychiatry and Neurology in General Psychiatry, Child and Adolescent Psychiatry, and Addiction Psychiatry.

Specializing in the diagnosis and pharmacological treatment of children and adults with ADHD, bipolar, substance use disorders, and other psychopathological conditions, Dr. Wilens cares for patients, supervises clinical trials, and consults on difficult cases.

Widely published, Dr. Wilens has more than 550 original articles, reviews, chapters, and editorials to his credit; and has written or coedited 6 books. He is a regular presenter at national and international meetings and sought as a speaker outside his academic responsibilities. He serves on the editorial boards of several journals and is a reviewer for many other journals. He is a distinguished fellow in the American Psychiatric Association and the American Academy of Child and Adolescent Psychiatry - where he also serves as President-elect.

Back to top